Brief: Inovio Announces Pricing Of $25 Million Public Offering
Nov 11 (Reuters) - Inovio Pharmaceuticals Inc INO.O: INOVIO ANNOUNCES PRICING OF $25 MILLION PUBLIC OFFERING INOVIO PHARMACEUTICALS INC - PRICES PUBLIC OFFERING OF 13,158,000 SHARES AT $1.90 EACH Source text: ID:nPnbCHl98a Further company coverage: INO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million